HR 3010119th CongressIntroduced

No Handouts for Drug Advertisements Act

Standard Summary
Balanced plain-English summary

The bill amends the Internal Revenue Code to prohibit tax deductions for direct-to-consumer advertising expenses of certain prescription drugs and compounded drugs, aiming to curb pharmaceutical industry incentives for consumer-targeted marketing.

Key Points

  • 1Denies tax deductions for DTC advertising of covered drugs via media like TV, social media, and digital platforms
  • 2Excludes advertisements in journals and periodicals from the DTC definition
  • 3Defines covered entities as prescription drug sponsors and outsourcing facilities under FDCA regulations

Impact Areas

Pharmaceutical companiesHealthcare consumersHealthcare cost containment effortsIRS tax deduction enforcement
Generated by gpt-4oNov 6, 2025